Fecal Calprotectin Dosage Value as A Diagnostic and Postoperative Marker in Diabetic Patients with Colorectal Cancer
Romanian Journal of Diabetes Nutrition and Metabolic Diseases · 2015
DOI: 10.1515/rjdnmd-2015-0002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Romanian Journal of Diabetes Nutrition and Metabolic Diseases, 2015. Verfasst von Ioan Lucian Borza und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0).
Abstract (Originalsprache)
Background and Aims: We evaluated fecal calprotectin values in patients with colorectal neoplasms undergoing surgery, comparatively in patients with and without diabetes mellitus. Material and Methods: We studied 40 patients operated for colorectal neoplasm, divided into two groups: one group of 20 patients with insulin-treated type 2 diabetes and another group of 20 patients without diabetes.
Results
Patients had a high percentage of preoperative calprotectin test positivity (90%, 36 patients). A total of 19 patients in group 1 and 17 patients in group 2 had a positive calprotectin test. Postoperatively at 3 months, fecal calprotectin values remained elevated in 7 patients from group 1 and 4 patients from group 2. At 6 months postoperatively, fecal calprotectin values remained elevated in 2 patients from group 1 and 1 patient from group 2.
Conclusions
Calprotectin values in faeces from patients with colorectal cancer were significantly increased, with a trend towards post-operatory normalization, slower in patients with diabetes. Fecal calprotectin value as a screening marker was almost equal compared to the hemoccult test, and better compared to that of the carcinoembryonic antigen.
Zitieren
APA
Borza, I. L., & Babes, A. (2015). Fecal Calprotectin Dosage Value as A Diagnostic and Postoperative Marker in Diabetic Patients with Colorectal Cancer. Romanian Journal of Diabetes Nutrition and Metabolic Diseases. https://doi.org/10.1515/rjdnmd-2015-0002
Vancouver
Borza IL, Babes A. Fecal Calprotectin Dosage Value as A Diagnostic and Postoperative Marker in Diabetic Patients with Colorectal Cancer. Romanian Journal of Diabetes Nutrition and Metabolic Diseases. 2015. doi:10.1515/rjdnmd-2015-0002
BibTeX
@article{Borza2015,
author = {Borza, Ioan Lucian and Babes, Aurel},
title = {Fecal Calprotectin Dosage Value as A Diagnostic and Postoperative Marker in Diabetic Patients with Colorectal Cancer},
journal = {Romanian Journal of Diabetes Nutrition and Metabolic Diseases},
year = {2015},
doi = {10.1515/rjdnmd-2015-0002}
}
EUVIMED